Bethyl Laboratories
Mouse anti-MCT4 Monoclonal Antibody [BLGM113]New
Primary
Catalog #A501-113
TargetMCT4
HostMouse
CloneBLGM113
ReactivityHuman
ApplicationIHC
Image 1 of 1
local_shipping
This item has an estimated lead time of two weeks.
Product Description
Monocarboxylate transporter 4 (MCT4) is a proton-linked monocarboxylate transporter. It catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate (By similarity) [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/O15427].
Specifications
Clonality
Monoclonal
Clone
BLGM113
Host
Mouse
Isotype
IgG3
Reactivity
Human
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Purified
Target Identity
TargetMCT4
Antigen Species
Human
Gene ID9123
Gene Symbol
SLC16A3
Gene Name
solute carrier family 16 member 3
Uniprot IDO15427
Protein Name
Monocarboxylate transporter 4
Alternate Names
MCT 3 • MCT 4 • MCT3 • MCT-3 • MCT4 • MCT-4 • monocarboxylate transporter 3 • monocarboxylate transporter 4 • solute carrier family 16 (monocarboxylate transporter), member 3 • solute carrier family 16 (monocarboxylic acid transporters), member 3 • Solute carrier family 16 member 3 • solute carrier family 16, member 3 (monocarboxylic acid transporter 4)
Product Information
Applications
IHC
Buffer
Tris-buffered Saline with 1% BSA and <0.1% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Applications
Immunohistochemistry (IHC)1:50 to 1:200
Documents
Product DatasheetPDF · A501-113 · Lot 1 (current lot)Open
Product DatasheetPDF · A501-113 · Lot 1 (current lot)Open
Safety Data SheetPDF · A501-113Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



